The Knee Injury and Osteoarthritis Outcome Score (KOOS) is one of the most used Patient-Reported Outcome Measures (PROMs) assessing pain, function and quality of life in people suffering from knee injury and osteoarthritis.
During this webinar, the developer Professor Ewa Roos will give an overview of KOOS with focus on interpretability and use in clinical studies:
- Learn about the KOOS development and the gap it filled. See how attitudes towards PROMs have changed, and reflect on the pros and cons of current outcome assessment methods.
- The KOOS 5-subscale structure is demystified. You will receive advice on how to optimize the use of KOOS and how to avoid multiplicity in a trial context.
- What level of problems does a KOOS subscale score of 78 represent? Insights include scoring direction, categorization, minimal important difference, patient acceptable symptom state, and treatment failure for clinical interpretation of KOOS scores.
- Discover the alternatives to the original KOOS: KOOS-12 and KOOS-Child.
After administering and making the KOOS freely available for more than 20 years via a personal website, Professor Roos chose to partner with Mapi Research Trust, as of May 2023, for the distribution and licensing of the KOOS. The speakers will detail the practical conditions of access to the KOOS and share information on the available translations. The KOOS free to use for non-funded and funded academic users. Commercial users and health care organizations must pay a fee. In both cases, authorization for use is always required.
Speakers
Professor Ewa Roos
Professor Roos has the passion to advance the frontiers of knowledge in muscle and joint health. Her focus is on patient-reported outcomes, exercise therapy, surgical treatments, and clinical care pathways.
Professor Roos is an internationally leading researcher and change agent in the field of musculoskeletal health. She is the author of 300+ peer-reviewed publications, including ground-breaking randomized trials comparing exercise therapy to orthopedic surgery published in high-impact journals, such as the New England Journal of Medicine and the British Medical Journal. Her work is cited 26.000+ times and her H-index is 74. She has been able to produce high-impact methodological and clinical research and translate that research into Patient-Reported Outcome Measures (PROMs) including the KOOS, HOOS, and FAOS and clinical tools such as Good Life with Osteoarthritis in Denmark (GLA:D®) available in 10 countries where more than 100.000 patients have received evidence-based osteoarthritis care.
Katie Flynn
Katie has over 10 years’ experience in account management and international business development in multi-channel sales, where she gained extensive client services experience. In 2023, Katie joined the Author Collaboration Unit at Mapi Research Trust to establish new collaborations with the authors and/or copyright holders of clinical outcome assessments (COAs) and assist them with the daily management of their questionnaires.
Who should attend?
As the KOOS is used to assess changes induced by treatment (medication, surgery, rehabilitation) or over the years (primary knee injury, posttraumatic, early and established osteoarthritis), this webinar will bring valuable insights to all practitioners and clinical researchers specializing in knee injuries and osteoarthritis, including:
- Orthopedic surgeons
- Rheumatologists
- Physical Therapists
- Medical experts, clinical research coordinators, project managers and clinical trial managers from pharmaceutical, biotech and medical device companies
What you will learn
- Learn about the KOOS development and the gap it filled.
- Receive advice on how to optimize the use of KOOS and how to avoid multiplicity in a trial context.
- Get insights on scoring direction, categorization, minimal important difference, patient acceptable symptom state, and treatment failure for clinical interpretation of KOOS scores.
- Discover the alternatives to the original KOOS: KOOS-12 and KOOS-Child.
- Learn more about the KOOS’ conditions of access and available translations.